share_log

Expert Outlook: Axsome Therapeutics Through The Eyes Of 8 Analysts

Expert Outlook: Axsome Therapeutics Through The Eyes Of 8 Analysts

專家展望:8位分析師眼中的Axsome Therapeutics
Benzinga ·  2024/12/30 22:00
8 analysts have expressed a variety of opinions on Axsome Therapeutics (NASDAQ:AXSM) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去一個季度中,8位分析師對Axsome Therapeutics(納斯達克:AXSM)表達了各種意見,提供了從看好到看淡的多樣化觀點。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下面的表格中,您將找到他們最近評級的摘要,揭示了過去30天情緒的變化,並與前幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $139.75, along with a high estimate of $180.00 and a low estimate of $116.00. This current average has increased by 0.45% from the previous average price target of $139.12.
分析師提供更深入的見解,設定了12個月的價格目標,表明平均目標爲139.75美元,最高預估爲180.00美元,最低預估爲116.00美元。這個當前的平均值相比於之前139.12美元的平均價格目標上升了0.45%。
Deciphering Analyst Ratings: An In-Depth Analysis
分析師評級解讀:深入分析
In...
在...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論